Benefit of using renal sodium-glucose cotransporter inhibitors 2 (iSGLT-2) in patients with type 2 Diabetes Mellitus and Heart Failure. (2020). Electronic Journal Collection Health, 12(9), e4349. https://doi.org/10.25248/reas.e4349.2020